Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Nephrology and Genetic Kidney Disorders (ICNGKD - 26) is a hybrid event for researchers, academics, and clinicians, aiming to foster collaboration and disseminate the latest research in the diagnosis, pathophysiology, and management of genetic kidney diseases.
Join leading experts, researchers, and practitioners at the International Conference on Nephrology and Genetic Kidney Disorders (ICNGKD - 26). This hybrid conference provides a premier platform to discuss the latest innovations, trends, and concerns in the field. The event focuses on advancing scientific progress by tackling challenges in nephrology and genetic kidney disorders through insightful lectures, presentations, and networking sessions. Attendees will have the opportunity to connect with a global community, share their research findings, and gain valuable insights into molecular mechanisms, genetic testing, clinical perspectives on inherited diseases, and new approaches to renal health management.
Applications and challenges in identifying genetic variants associated with kidney disease.
Exploring novel molecular and genetic markers for early detection and monitoring.
Tailoring drug therapies based on genetic profiles to improve efficacy and reduce toxicity.
Understanding how environmental factors influence the expression of genetic kidney diseases.
Investigating the signaling pathways and cellular processes that lead to renal damage in genetic disorders.
The role of epigenetic modifications in the development and progression of nephropathies.
Latest updates on diagnosis, management, and therapeutic interventions for ADPKD and ARPKD.
Clinical presentation, genetic diagnosis, and emerging treatments.
Case studies and management strategies for less common inherited renal conditions.
Exploring cutting-edge treatments, including gene editing and targeted molecular therapies.
Utilizing digital health technologies to improve access to care for patients with genetic kidney diseases.
Developing integrated care models that address the complex needs of patients and families.
Best practices for communicating genetic risk and test results to patients and families.
Addressing the challenges of protecting sensitive genetic information in research and clinical settings.
Discussing strategies to ensure equitable access to genetic testing and advanced therapies for all populations.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
